Conference Menu
Current Event OverviewDay 1Day 2Short CoursesPDF DownloadPress Pass Request Brochure
Current Event
OverviewDay 1Day 2Short CoursesPDF DownloadPress Pass Request Brochure
Recent Publications
Published March 2009
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
Order your copy today!
FFPE and RNA Extraction
Published Genome Technology July 2009
Advances in Gene Expression Profiling PDF Download
Corporate Sponsors
Sponsoring Publication
Sponsoring Organization
Web Partner
Advances in molecular high-throughput assays for gene expression (DNA/RNA) signatures have generated the parallel need for well annotated properly preserved biospecimens. Samples from both diseased and unaffected normal tissues are often required. Like traditional banks, biobanks are meant to be used and are most useful when the needs of end-users (researchers) are considered. Thus, a well managed biobank is a critical prerequisite for high-quality biological research. Cambridge Healthtech Institute’s Inaugural The Science of Biobanking is uniquely designed to explore the critical interactions between bioDEPOSITORS, bioBANKERS, and bioRECIPENTS who are all invested in the future of bioMOLECULAR research.
Session Topics Include:
KEYNOTE SPEAKERS
Carolyn Compton, M.D., Ph.D. Director, Biorepositories & Biospecimen Research National Cancer Institute Elizabeth Mansfield, Ph.D. Director, Personalized Medicine Staff, Office of In Vitro Diagnostic Devices CDRH/FDA
Pre-Conference Short Course* – Sunday, November 15
2:00 - 5:00 pm Scientific & Technical Considerations for Development & Managing Biobanking Protocols
The biospecimen research protocol is the cornerstone of any research utilizing precious biological samples and serves as a crucial tool to support both large and small biobanking programs. Determining the quality of biological specimens continues to be a significant challenge for all research programs as investigators struggle to delineate biological change from specimen artifact. Both financial and specimen management are interrelated components of any archival strategy which require careful management to ensure the quality and accessibility of renewable and more importantly, non-renewable biological resources. The management of biorepository protocols is one of the largest and most important considerations when calculating costs in biobanking programs today, putting sustainable quality operations of biospecimen resources at risk. While often overlooked, proactive management and design of biobanking protocols can dramatically improve & address critical issues helping most programs achieve the quality required for serving their community. This workshop will present an in-depth overview and discussion of the following topics:
Who Should Attend? Biospecimen Resource Directors, Lab Managers, Technicians, Scientists & Biobank End Users, Regulatory & Informatics Professionals and Policymakers & Grant Writers/Managers
Course Instructors: Andrew Brooks, Ph.D., Director, Bionomics Research & Technology, Rutgers University Cell and DNA Repository, RUCDR
Lisa Miranda, President, Biobusiness Consulting Inc.; Former Technical Director, TTAB Core Facility, University of Pennsylvania * Separate registration required